Jiang Zheng

Jiang Zheng

Auto-generated profile, based on publicly available information

Jiang Zheng

Sports Medicine Center, Honghui Hospital, Xi'an Jiaotong University, Xi'an, Shaanxi 710054, P.R. China

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
3 October 2022 in Frontiers in Nutrition
Verified
Journal Article
Open access
ACAiyong Cui
Aiyong Cui
PXPeilun Xiao
Peilun Xiao
YMYuzhuo Ma
Yuzhuo Ma
ZFZhiqiang Fan
Zhiqiang Fan
FZFengjin Zhou
Fengjin Zhou
LZLiang Zhang
Liang Zhang
Background: The National Health and Nutrition Examination Surveys (NHANES) collect and release data to the public every 2 years. The latest NHANES study on the vitamin D status of Americans was based on data from 2001 to 2014, and the latest data (2015–2016 and 2017–2018) have not been studied yet. Thus, we extracted all the available data from NHANES (2001–2018), aiming to analyze the prevalence and trends of vitamin D deficiency (VDD) in the US population to bridge the research gap.Methods: According to previous studies and nutritional guidelines for vitamin D, severe VDD was defined as serum 25(OH)D levels of 75 nmol/L. We comprehensively estimated the prevalence of serum 25(OH)D levels of 75 nmol/L in Americans and described trends in vitamin D status from 2001 to 2018. Weighted multivariate linear regression models were used to explore the predictors of VDD. All analyses and the data were adjusted for the complex sampling design of NHANES using Mobile Examination Center (MEC) weights.Results: Based on the most recent data of 71,685 participants, our study showed that the weighted prevalence of severe and moderate VDD was 2.6% and 22.0%, and the prevalence of vitamin D insufficiency (VDI) and sufficiency was 40.9% and 34.5%. The prevalence of severe and moderate VDD was higher in women, non-Hispanic black Americans, people aged 20–29 years, and during the season of winter. From 2001 to 2018, we found a slight linear decrease in the prevalence of moderate VDD (coefficient = −0.847; P = 0.009) and VDI (coefficient = −0.810; P = 0.014). We also found a slight linear increase in vitamin D sufficient (coefficient = 1.693; P = 0.004). However, no trend change was observed in severe VDD (coefficient = −0.037; P = 0.698). Age, sex, ethnicity, season, sun-protective behaviors, lower BMI, lower socioeconomic status (SES), drinking, and lower milk consumption were predictors of severe VDD.Conclusion: Vitamin D deficiency is still prevalent in the United States, especially in non-Hispanic black Americans, women, individuals aged 20–29, and during winter. Therefore, individuals, healthcare providers, and policymakers should take public health measures to develop and implement prevention strategies to deal with VDD.

1 August 2019 in Archives of orthopaedic and trauma surgery
Verified
Journal Article
Closed access
BRBo Ren
Bo Ren
XZXian Zhang
Xian Zhang
LZLiang Zhang
Liang Zhang
MZMingyu Zhang
Mingyu Zhang
YLYang Liu
Yang Liu
JZJiang Zheng
Jiang Zheng

1 August 2020 in Genetic Testing and Molecular Biomarkers
Verified
Journal Article
Closed access
ZZZandong Zhao
Zandong Zhao
LZLiang Zhang
Liang Zhang
XKXin Kang
Xin Kang
JZJiang Zheng
Jiang Zheng
BTBin Tian
Bin Tian
Background: Multiple lines of evidence have suggested that genetic factors may contribute to steroid-induced osteonecrosis of the femoral head (SONFH). Complement receptor 2 (CR2), constituting a family of regulators of complement activation, has been recently reported to be associated with osteonecrosis of the femoral head (ONFH) in Koreans. The aim of this study was to evaluate the relationships between the CR2 gene and susceptibility to SONFH in the male Han Chinese population. Materials and Methods: A total of 468 SONFH patients and 1224 healthy controls were recruited to the study. Ten tag single nucleotide polymorphisms (SNPs) located within the CR2 gene were genotyped. Genetic association analyses, including SNP and haplotypic analyses, were performed for the 10 SNPs. Furthermore, bioinformatic analyses were conducted to examine the functional consequences of significant SNPs. Results: An intronic SNP, rs311306, was identified to be significantly associated with the risk of SONFH (p = 0.0008, odds ratio = 1.44). Allelic analyses showed that the C allele of this SNP significantly elevated the risk of SONFH, which was replicated in genotypic association analyses. Moreover, a 3-SNP haplotype was significantly associated with SONFH (rs311306–rs17044576–rs3767933, p = 7.49 × 10−8). Furthermore, bioinformatic analysis results indicated limited functional consequences of SNP rs311306, but a complex interaction network was constructed by the protein encoded by the SLC44A2 gene and proteins encoded by CD19, CD81, and C3 genes. Conclusion: Our findings shed new light on the link between the CR2 gene and SONFH in Han Chinese males, providing clues as to the nature of the mechanisms involved in the etiology of ONFH.

31 October 2025 in Molecular Medicine Reports
Verified
Journal Article
Open access
RZRuipu Zhang
Ruipu Zhang
LZLiang Zhang
Liang Zhang
BTBin Tian
Bin Tian
YWYiqun Wang
Yiqun Wang
XKXin Kang
Xin Kang
JZJiang Zheng
Jiang Zheng
Osteoarthritis (OA) is a prevalent chronic joint disorder with a notable global health burden, characterized by articular cartilage degeneration, abnormal bone remodeling and synovial inflammation. Traditional treatments mainly focus on symptom management rather than addressing the underlying disease mechanisms. The gut microbiome serves a potential role in OA through the gut‑bone‑cartilage axis. Notably, the gut microbiome and its metabolites can influence bone and cartilage homeostasis, and the Wnt/β‑catenin signaling pathway has been implicated in OA pathogenesis. The present study comprehensively reviews the emerging evidence supporting the gut‑bone‑cartilage axis in OA and the role of microbial regulation of Wnt/β‑catenin signaling in joint remodeling. The current understanding of the influence of the gut microbiome on OA pathogenesis is summarized, discussing the mechanisms underlying the gut‑bone‑cartilage axis and exploring the therapeutic potential of targeting this axis. Future research should focus on developing targeted therapies that modulate the gut microbiome and the Wnt/β‑catenin pathway, as well as exploring the potential of gene editing and carrier technologies for OA treatment.

22 June 2026 in International Journal of Molecular Medicine
Verified
Journal Article
Open access
RZRuipu Zhang
Ruipu Zhang
LZLiang Zhang
Liang Zhang
YWYiqun Wang
Yiqun Wang
XKXin Kang
Xin Kang
JZJiang Zheng
Jiang Zheng
Osteoarthritis has evolved from a mechanical concept to a metabolic whole‑organ disease driven by systemic inflammation. The 'gut‑joint axis' represents a 'biological highway' where intestinal dysbiosis permits the translocation of microbial metabolites into synovial joints. This review focuses on three pivotal metabolite classes with opposing roles: Short‑chain fatty acids (SCFAs), which function as anti‑inflammatory guardians; trimethylamine N‑oxide (TMAO), which acts as a pro‑inflammatory aggressor; and bile acids (BAs), which serve as complex regulators that balance homeostasis and catabolism. This review further proposes a novel 'metabolite homeostasis imbalance' theoretical framework, which posits that osteoarthritis pathogenesis is driven by the disruption of the dynamic equilibrium between protective (SCFAs), destructive (TMAO) and context‑dependent regulatory (BAs) microbial metabolites. This integrative 'metabolite homeostasis imbalance' model deconstructs the 'biological highway' metaphor into a three‑tier mechanistic schema encompassing intestinal barrier integrity, systemic metabolite trafficking and tissue‑specific effector functions in the joint microenvironment, thereby providing a unifying conceptual foundation bridging scattered single‑metabolite research and mechanism‑targeted precision OA management. Additionally, the potential of sports medicine interventions, including exercise and probiotics, to modulate this axis is evaluated. This synthesis provides a comprehensive theoretical basis for novel clinical strategies targeting gut‑derived metabolic networks to preserve joint health and mitigate disease progression.